Compass Pathways

Compass Pathways is a pharmaceutical company that develops active substance psilocybin for the treatment of patients with treatment resistant depression. Compass Pathways was incorporated in 2020 and is based in Cheshire, the United Kingdom.
Compass Pathways stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Compass Pathways balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Compass Pathways cash flows

Report period2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Compass Pathways multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Compass Pathways profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Compass Pathways assets
Compass Pathways cash flows

Compass Pathways dividend policy

The company doesn't provide dividend

Compass Pathways shares

TickerNameTypeNominal valueISINPrice
CMPS:USCompass PathwaysCommon share-US20451W1018$5.04
Compass Pathways news
10.05.2022
Compass Pathways' GAAP loss for 3 months of 2022 was $21.171 million, up 66.5% from $12.715 million in the previous year.
Source: ir.compasspathways.com pictogram ir.compasspathways.com
Pictogram next
24.02.2022
Compass Pathways' GAAP loss for 2021 was $71.742 million, up 18.9 percent from $60.334 million the previous year.
Source: ir.compasspathways.com pictogram ir.compasspathways.com
Pictogram next
09.11.2021
Compass Pathways' GAAP loss for 9M 2021 was $46.092 million, up 11% from $41.528 million in the prior year.
Source: ir.compasspathways.com pictogram ir.compasspathways.com
Pictogram next
11.08.2021
Compass Pathways' GAAP loss for 6M 2021 was $30.243 million, up 21.8% from $24.834 million in the prior year.
Source: ir.compasspathways.com pictogram ir.compasspathways.com
Pictogram next
All Compass Pathways news
General information
Company nameCompass Pathways
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address1 Ashley Road 3rd Floor Altrincham, WA14 2DT United Kingdom
Mailing address1 Ashley Road 3rd Floor Altrincham, WA14 2DT United Kingdom
Websiteir.compasspathways.com
Information disclosurewww.sec.gov